We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
We want to remind healthcare professionals that use of systemic (oral and injectable) NSAIDs such as ibuprofen, naproxen, and diclofenac is contraindicated in the last trimester of pregnancy (after 28 weeks of pregnancy).
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
Guidance on the cardiovascular safety of Cox-2 inhibitors and NSAIDs and further reading.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Evaluations made by the Rapid Review Panel (RRP) on submitted products.
Government Chemist publishes definitive approaches for the authentication of chondroitin
Product Safety Report for CT Cosmetics Extra Pure White Gold Glowing, B.S.C. Black Spot Corrector presenting a serious chemical risk.
How to label and package olive oil and olive oil products, and which records to keep for product inspections.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).